An Arginine-Vasopressin V2 receptor Antagonist, Tolvaptan, for Treatment of Heart Failure with Volume Overload - Evidence from Nonclinical Studies to Clinical Trials
Special Issue" Myocardial Metabolism - Therapeutic Aspects; Proceedings of the 5th International Conference of the Society for Heart and Vascular Metabolism - Maastricht 2007, Guest Editors: Jan F. C. Glatz and William C. Stanley